Muhammad Ashraf
M.Sc.
muwaas@utu.fi ORCID-tunniste: https://orcid.org/0000-0002-9947-1579 |
Pharmacokinetics
Clinical Pharmacokinetics
Pharmacokinetic-Pharmacodynamic Modeling
Population PK/PD
Non-linear Mixed Effects Modeling
NONMEM
R
Education:
I am working in the field of pharmacometrics, where I use the 'population approach' (i.e. non-linear mixed effects modeling) to describe the pharmacokinetic (PK) and/or pharmacokinetic-pharmacodynamic (PK-PD) behaviors of drugs in the human body. I am applying these concepts to data from ongoing clinical trials, that are being actively carried out at the Turku University Hospital, with anesthetic agents and pain medications. The rationale is to elucidate the optimal dosing schemes for these drugs for use in pain medicine, in an attempt to implement precision medicine in this area of medical care provision.
Pharmacology
Clinical Pharmacology
Pharmacokinetics
Population PK/PD Modeling
- Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration (2020)
- Clinical Pharmacokinetics
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1)) - Semimechanistic Population Pharmacokinetic Model to Predict the Drug–Drug Interaction Between S-ketamine and Ticlopidine in Healthy Human Volunteers (2018)
- CPT: Pharmacometrics and Systems Pharmacology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))